• News
  • SAN DIEGO
  • BioTech

Zohydro details timeframe for new Zohydro version

The San Diego drugmaker Zogenix says a harder-to-abuse version of its powerful painkiller Zohydro could be reviewed by regulators this fall and, if approved, might hit the market early next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ZGNX
1.27
  0.01  
+ 0.79%
617,109,000
5.19
1.07

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer
Subscribe Today!